Prabhu, LakshmiMundade, RasikaWang, BenlianWei, HanHartley, Antja-VoyMartin, MatthewMcElyea, KyleTemm, Constance J.Sandusky, GeorgeLiu, YunlongLu, Tao2016-03-312016-03-312015-10-06Prabhu, L., Mundade, R., Wang, B., Wei, H., Hartley, A.-V., Martin, M., … Lu, T. (2015). Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer. Oncotarget, 6(30), 29396–29412. Retrieved from http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=51201949-2553https://hdl.handle.net/1805/9146Y-box binding protein 1 [YBX1] is a multifunctional protein known to facilitate many of the hallmarks of cancer. Elevated levels of YBX1 protein are highly correlated with cancer progression, making it an excellent marker in cancer. The connection between YBX1 and the important nuclear factor κB [NF-κB] has never been reported. Here, we show that overexpression of wild type YBX1 [WT-YBX1] activates NF-κB, suggesting that YBX1 is a potential NF-κB activator. Furthermore, using mass spectrometry analysis we identified novel phosphorylation of serine 165 [S165] on YBX1. Overexpression of the S165A-YBX1 mutant in either HEK293 cells or colon cancer HT29 cells showed dramatically reduced NF-κB activating ability as compared with that of WT-YBX1, confirming that S165 phosphorylation is critical for the activation of NF-κB by YBX1. We also show that expression of the S165A-YBX1 mutant dramatically decreased the expression ofen-USCC-BYcolon cancerNF-κBphosphorylationserineYBX1Article